Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Centessa Pharmaceuticals Plc ADR (CNTA)

Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

KZR : 7.33 (-0.54%)
CNTA : 39.66 (+0.33%)
APLS : 40.90 (+0.07%)
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS

NEW YORK , April 8, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of...

AFBI : 22.39 (+0.13%)
KZR : 7.33 (-0.54%)
CNTA : 39.66 (+0.33%)
APLS : 40.90 (+0.07%)
Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

KORE : 9.14 (-0.11%)
CNTA : 39.66 (+0.33%)
APLS : 40.90 (+0.07%)
The Next Big AI Winner Might Not Be a Tech Company

Lilly’s AI push shows how non-tech firms can dominate the next wave.

NVDA : 201.68 (+1.68%)
$SPX : 7,126.06 (+1.20%)
CNTA : 39.66 (+0.33%)
LLY : 927.03 (+2.55%)
Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience

Eli Lilly is securing its future by investing in AI drug discovery and expanding its pipeline into the multi-billion-dollar neuroscience market.

CNTA : 39.66 (+0.33%)
LLY : 927.03 (+2.55%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA)

NEW YORK , April 1, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions...

CNTA : 39.66 (+0.33%)
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Centessa Pharmaceuticals...

CNTA : 39.66 (+0.33%)
LLY : 927.03 (+2.55%)
Stocks Surge on Signs the US and Iran Seek to End War

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +2.91%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +2.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +3.43%. June E-mini...

ALK : 45.40 (+10.33%)
GOOGL : 341.68 (+1.68%)
AAPL : 270.23 (+2.59%)
SNDK : 920.99 (+0.17%)
ADI : 371.45 (+4.99%)
CNTA : 39.66 (+0.33%)
OXY : 53.79 (-5.42%)
TSLA : 400.62 (+3.01%)
STX : 547.75 (+3.00%)
WDC : 372.52 (+2.99%)
SPY : 710.14 (+1.21%)
META : 688.55 (+1.73%)
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders

MILWAUKEE , March 31, 2026 /PRNewswire/ -- LLP is investigating Centessa (NASDAQ: CNTA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with...

CNTA : 39.66 (+0.33%)
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

BIRD : 10.80 (-1.01%)
CNTA : 39.66 (+0.33%)
APLS : 40.90 (+0.07%)

Barchart Exclusives

Applebee’s and IHOP Owner Dine Brands Looks Ripe For A Buyout
Dine Brands has already rallied on activist pressure, but with Applebee’s and IHOP still trading below their strategic value, private equity could be the next catalyst. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.